Back to search

United Kingdom· GB-APID-40538311000001100

Zonisamide 25mg capsules

A zonisamide product containing zonisamide, registered in United Kingdom by Aspire Pharma Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX15

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedZonisamide 25mg capsulesATCN03AX15REGISTER NO.GB-APID-4053831100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Zonisamide is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX15 (zonisamide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Zonisamide · ATC N03AX15

18 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zonisamide costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.78 in United States to $10.28 in Switzerland — a ×13 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Zonisamide · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$10.28
  • IT Italy$2.90
  • FR France$1.20
  • US United States$0.78 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Zonisamide
Manufacturer
Aspire Pharma Ltd
Country
United Kingdom (GB)
ATC code
N03AX15
ATC class
Zonisamide
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060209732947

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

239 interactions on record for zonisamide.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zonisamide · interactions on record

239 records

  • 43 severe
  • 105 moderate
  • 66 info

Most severe, free to view

  • DicycloverineA03AA07severe
  • PropanthelineA03AB05severe
  • MepenzolateA03AB12severe
  • TrospiumA03AB20severe

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zonisamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zonisamide products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Zonisamid Aristo
  • Bulgaria · Зокап
  • Czechia · Ersittin, Zonisamid Sandoz
  • Germany · Zonisamid 1 A Pharma, Zonisamid Accord
  • Denmark · Zonisamid Desitin, Zonisamid Glenmark
  • Estonia · Zonisamide Sandoz
  • Spain · Nyzol, Zonesme
  • Finland · Zonisamide Desitin
  • France · Zonisamide Arrow, Zonisamide Neuraxpharm
  • Croatia · Zocap
  • Ireland · Zonisamide Desitin, Zonisamide Rowex
  • Iceland · Zonegran, Zonisamide Viatris
  • Italy · Zonisamide Doc Generici, Zonisamide Sandoz
  • Liechtenstein · Zonegran, Zonisamide Viatris
  • Lithuania · Zonisamide Sandoz
  • Malta · Zonisamide Doc Generici
  • Netherlands · Zonisamide Indoco, Zonisamide Sandoz
  • Norway · Zonegran, Zonisamid Desitin
  • Poland · Zonisamidum Neuraxpharm
  • Portugal · Zonisamida Aristo, Zonisamida Generis
  • Romania · Zocap, Zonisamidă Desitin
  • Sweden · Zonisamide 1a Farma
  • Slovenia · Zocap, Zonisamid Sandoz
  • Slovakia · Zonisamide Neuraxpharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b099f727-832c-44aa-8a25-67aa8c9b862d
GET /v1/drugs/b099f727-832c-44aa-8a25-67aa8c9b862d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "40538311000001100",
  "desc": "Zonisamide 25mg capsules (Aspire Pharma Ltd)",
  "form": "Oral capsule",
  "vpid": "42139111000001105",
  "source": "dmd",
  "vtm_id": "777991006",
  "strength": "25 mg",
  "substance": "Zonisamide",
  "ingredient": "Zonisamide",
  "supplier_code": "16666911000001109"
}

See everything about zonisamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.